Companies / Envoy Medical, Inc. / Activity
Activity — Envoy Medical, Inc.
20 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Glen A. Taylor 10% owner | Buy | Class A Common Stock | $7.50M | +18.8M +634.82% | 21,703,607 28.12% of shares | high |
| Feb 12, 2026 | Brynelsen Charles Director | Buy | Class A Common Stock | $400.0K | +1.0M +2000.00% | 1,050,000 1.36% of shares | medium |
| Feb 12, 2026 | Patel Mona Chetan Director | Buy | Class A Common Stock | $125.0K | +313K +1562.50% | 332,500 0.43% of shares | medium |
| Feb 12, 2026 | Potashnick Robert Executive | Buy | Class A Common Stock | $85.0K | +213K | 212,500 0.28% of shares | medium |
| Feb 12, 2026 | Kantor Susan Director | Buy | Class A Common Stock | $38.5K | +96K +123.45% | 174,037 0.23% of shares | low |
| Feb 12, 2026 | Lucas Brent T. CEO | Buy | Class A Common Stock | $25.0K | +63K +26.64% | 297,090 0.38% of shares | low |
| Feb 12, 2026 | Glen A. Taylor 10% owner | Buy | Warrant Shares (Series A-2) | — | +18.8M | 18,750,000 24.29% of shares | low |
| Feb 12, 2026 | Glen A. Taylor 10% owner | Buy | Warrant Shares (Series A-1) | — | +11.3M | 11,250,000 14.57% of shares | low |
| Feb 12, 2026 | Patel Mona Chetan Director | Buy | Warrant (right to buy) | — | +313K | 312,500 0.40% of shares | low |
| Feb 12, 2026 | Patel Mona Chetan Director | Buy | Warrant (right to buy) | — | +188K | 187,500 0.24% of shares | low |
| Feb 12, 2026 | Potashnick Robert Executive | Buy | Warrant (right to buy) | — | +213K | 212,500 0.28% of shares | low |
| Feb 12, 2026 | Potashnick Robert Executive | Buy | Warrant (right to buy) | — | +128K | 127,500 0.17% of shares | low |
| Feb 12, 2026 | Kantor Susan Director | Buy | Warrant (right to buy) | — | +96K | 96,150 0.12% of shares | low |
| Feb 12, 2026 | Kantor Susan Director | Buy | Warrant (right to buy) | — | +58K | 57,690 0.07% of shares | low |
| Feb 12, 2026 | Brynelsen Charles Director | Buy | Warrant (right to buy) | — | +1.0M | 1,000,000 1.30% of shares | low |
| Feb 12, 2026 | Brynelsen Charles Director | Buy | Warrant (right to buy) | — | +600K | 600,000 0.78% of shares | low |
| Feb 12, 2026 | Lucas Brent T. CEO | Buy | Warrant (right to buy) | — | +63K | 62,500 0.08% of shares | low |
| Feb 12, 2026 | Lucas Brent T. CEO | Buy | Warrant (right to buy) | — | +38K | 37,500 0.05% of shares | low |
| Feb 5, 2026 | Potashnick Robert Executive | Grant | Stock Option (right to buy) | — | +15K | 15,000 0.02% of shares | low |
| Feb 5, 2026 | Lucas Brent T. CEO | Grant | Stock Option (right to buy) | — | +200K | 200,000 0.26% of shares | low |